Clinical TrialID 7752
Sitagliptin in Combination With Beidougen Capsule for Type 2 Diabetes
NCT05667220
Type 2 Diabetes
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Formula: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 7752
- Evidence Id
- 7752
- Core Evidence Id
- 7752
- Source Clinical Trial Id
- 7747
- Herb2 Clinical Trial Id
- HBCT007747
- Nct Id
- NCT05667220
- Title
- Sitagliptin in Combination With Beidougen Capsule for Type 2 Diabetes
- Status
- Recruiting
- Phase
- Phase 4
- Study Result
- No
- Study Condition
- Type 2 Diabetes
- Study Type
- Interventional
- Study Design
- Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: BASIC_SCIENCE
- Intervention
- DRUG: Sitagliptin|DRUG: Sitagliptin combined with Beidougen capsule
- Intervention Allocation
- Non_Randomized
- Intervention Model
- Parallel
- Intervention Mask
- Intervention Purpose
- Basic_Science
- Gender
- All
- Age
- Adult, Older_Adult
- Enrollment
- 20
- Outcome Measure
- Fasting blood glucose change, Fasting blood glucose (FBG) levels (mmol/L) were analyzed by an autoanalyzer (Hitachi 747, Roche Diagnostics, Germany) at the Central Chemistry Laboratory of Beijing Chaoyang Hospital affiliated with Capital Medical University., Changes in fasting blood glucose from baseline to 1 week treatment
- Sponsor Collaborator
- Beijing Chao Yang Hospital
- Funded By
- OTHER
- Location
- Beijing Chao-yang Hospital, Capital Medical University, Beijing, Beijing, 100020, China
- Other Id
- 2022-Sitagliptin-Beidougen
- Start Date
- 2022-12-01
- Primary Completion Date
- 2023-10-31
- Completion Date
- 2023-12-31
- First Posted
- 2022-12-28
- Results First Posted
- Last Update Posted
- 2023-01-03
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT05667220
- Title Cn
- Title En
- Sitagliptin in Combination With Beidougen Capsule for Type 2 Diabetes
- Bilingual Status
- semi_complete